Dr. Emslie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Child and Adolescent Psychiatry, 1978 - 1981
- University of RochesterResidency, Psychiatry, 1975 - 1978
- University of Aberdeen Faculty of MedicineClass of 1974
Certifications & Licensure
- CA State Medical License 1978 - Present
- TX State Medical License 1981 - 2025
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Treatment for Adolescents With Depression Study (TADS) Start of enrollment: 1998 Sep 01
- Determining Optimal Continuation Treatment Duration for Depressed Children and Adolescents Start of enrollment: 2000 Jun 01
- Sequential Treatment of Pediatric MDD to Increase Remission and Prevent Relapse Start of enrollment: 2008 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 118 citationsA double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescentsKaren Dineen Wagner, Robert A. Kowatch, Graham J. Emslie, Robert L. Findling, Timothy E. Wilens
The American Journal of Psychiatry. 2006-07-01 - 148 citationsPsychometric properties of the children's depression rating Scale-Revised in adolescentsTaryn L. Mayes, Ira H. Bernstein, Charlotte L. Haley, Betsy D. Kennard, Graham J. Emslie
Journal of Child and Adolescent Psychopharmacology. 2010-12-01 - 1 citationsProblematic substance use in depressed adolescents: Prevalence and clinical correlates.Elise N Marino, Manish K Jha, Abu Minhajuddin, Emine Rabia Ayvaci, Sara Levinson
Addictive Behaviors Reports. 2024-06-01
Authored Content
- Pharmacologic Management of Insomnia in Children and Adolescents: Consensus StatementJune 2006
Press Mentions
- Chapter 5: The Manufacture of Childhood Depression (Part 2)December 14th, 2020
- Childhood Anxiety Disorders Can and Should Be Treated, According to ExpertDecember 24th, 2008
- 27.0 Using the Newest Antidepressants: A Conversation for Child and Adolescent PsychiatristsOctober 25th, 2017
Grant Support
- Pediatric MDD: Sequential Treatment With Fluoxetine And Relapse Prevention CBTNational Institute Of Mental Health2008–2012
- Automated Interactive Text Messaging To Assess Adolescent DepressionNational Institute Of Mental Health2010
- Child Psychiatry Research Education Program (C-Prep)National Institute Of Mental Health2005–2008
- Treatment Of Ssri-Resistant Depression In AdolescentsNational Institute Of Mental Health2005–2006
- Treatment Of Adolescent Suicide Attempters In DallasNational Institute Of Mental Health2002–2006
- Childhood Depression: Remission And RelapseNational Institute Of Mental Health2001–2004
- Treatment Of SSRI Resistant Depression In AdolescentsNational Institute Of Mental Health2000–2004
- Treatment Of Early Age Mania (TEAM)National Institute Of Mental Health2002–2003
- Childhood Depression--Remission And RelapseNational Institute Of Mental Health2000
- Childhood Depression--Biological CorrelatesNational Institute Of Mental Health1994–1995
- Childhood Depression-Biological CorrelatesNational Institute Of Mental Health1991–1993
- Childhood Depression Biological CorrelatesNational Institute Of Mental Health1988
- Childhood Depression - Biological CorrelatesNational Institute Of Mental Health1986–1987
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: